Searching for specific responses to copper exposure: an in vitro copper challenge in peripheral mononuclear cells.
Acute and chronic cellular responses to changes in copper availability are not clear when these changes are mild to moderate, as what often occur in human daily life. The aims of the study were to develop an in vitro copper challenge in peripheral mononuclear cells (PMNCs) obtained from healthy individuals with different preconditioning copper treatments, and measure copper and iron content, and MT2A and TfR mRNA abundance after the copper challenge. (1) Screening using clinical and biochemical indicators defined healthy participants, who received 8 mg Cu/day (copper sulfate) or placebo for 2 months. (2) Mononuclear cells were obtained on days 0, 2 (acute changes), and 60 (chronic changes). (3) Cells were challenged with a 1, 5, and 20 μM Cu-histidine for 20 h, at T0, T2, and T60. Cells from both supplemented and placebo individuals showed a clear trend to increase copper content when there was more copper in the media. Increases were greater in the supplemented group, larger with 20 μM Cu (p < 0.02, one-way ANOVA), and mostly not significant when incubated with 5 μM Cu. By two-way ANOVA, differences were significant by treatment and by time (both p < 0.001). Differences between T0/T2 and T0/T60 were also significant (both p < 0.001). Changes of iron content were significant by treatment and time (two-way ANOVA); mRNA relative abundance of MT2A changed significantly and paralleled those of copper concentration, but TfR transcripts did not change. An in vitro challenge of PMNC showed specific changes of cellular copper and MT2A, while changes of iron content and TfR mRNA abundance were not consistent. PMNCs appear as good candidates to assess changes of cellular copper availability. That results differed after acute (T2) and chronic (T60) supplementation suggests that acute and chronic changes are handled differently by these cells.
Arredondo
Miguel
M
Institute of Nutrition and Food Technology (INTA), University of Chile, El Líbano 5524, Macul 5540, Casilla 13811, Santiago 11, Chile.
Espinoza
Alejandra
A
Pizarro
Fernando
F
Araya
Magdalena
M
D000328:Adult; D002570:Ceruloplasmin / Q000378:metabolism; D003300:Copper / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007501:Iron / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D008668:Metallothionein / Q000235:genetics; D008875:Middle Aged; D013482:Superoxide Dismutase / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics; D055815:Young Adult
C491053:MT2A protein, human; C527330:RTF1 protein, human; D014157:Transcription Factors; D003300:Copper; D008668:Metallothionein; D007501:Iron; D013482:Superoxide Dismutase; D002570:Ceruloplasmin